Nasdaq:US$15.97 (-0.33) | HKEX:HK$25.80 (+0.35) | AIM:£2.31 (+0)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility